A New Regioselective Synthesis of 1,2,5-Trisubstituted 1H-Imidazoles and Its Application to the Development of Eprosartan

Journal of Organic Chemistry

Volumn 62, Issue 24, 1997, Pages 8449-8454

  Shilcrat, Susan C ^a   Mokhallalati, Mohamed K ^a   Fortunak, Joseph M D ^a   Pridgen, Lendon N ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001656259     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo971304f     Document Type: Article

References (24)

1. Weinstock, J.; Keenan, R. M.; Samanen, J.; Hempel, J.; Finkelstein, J. A.; Franz, R. G.; Gaitanopoulos, D. E.; Girard, G. R.; Gleason, J. G.; Hill, D. T.; Morgan, T. M.; Peishoff, C. E.; Aiyar, N.; Brooks, D. P.; Fredrickson, T. A.; Ohlstein, E. H.; Ruffolo Jr., R. R.; Stack, E. J.; Sulpizio, A. C.; Weidley, E. F.; Edwards, R. M.; Reiter, L. A. J. Med. Chem. 1991, 34, 1514.
2. For other angiotensin II receptor antagonists, see (and references within): (a) Carini, D. J.; Duncia, J. V.; Johnson, A. L.; Chiu, A. T.; Price, W. A.; Wong, P. C.; Timmermans, P. B. J. Med. Chem. 1990, 33, 1330. (b) Carini, D. J.; Duncia, J. V.; Aldrich, P. E.; Chiu, A. T.; Johnson, A. L.; Pierce, M. E.; Price, W. A.; Santella, J. B., III; Wells, G. J.; Wexler, R. R.; Wong, P. C.; Yoo, S. E.; Timmermans, P. B. J. Med. Chem. 1991, 34, 2525. (c) Pierce, M. E.; Carini, D. J.; Huhn, G. F.; Wells, G. J.; Arnett, J. F. J. Org. Chem. 1993, 58, 4642. (d) Furukawa, Y.; Kishimoto, S.; Nishikawa, K. U.S. Patent 4,355,040 1982.
3. For other angiotensin II receptor antagonists, see (and references within): (a) Carini, D. J.; Duncia, J. V.; Johnson, A. L.; Chiu, A. T.; Price, W. A.; Wong, P. C.; Timmermans, P. B. J. Med. Chem. 1990, 33, 1330. (b) Carini, D. J.; Duncia, J. V.; Aldrich, P. E.; Chiu, A. T.; Johnson, A. L.; Pierce, M. E.; Price, W. A.; Santella, J. B., III; Wells, G. J.; Wexler, R. R.; Wong, P. C.; Yoo, S. E.; Timmermans, P. B. J. Med. Chem. 1991, 34, 2525. (c) Pierce, M. E.; Carini, D. J.; Huhn, G. F.; Wells, G. J.; Arnett, J. F. J. Org. Chem. 1993, 58, 4642. (d) Furukawa, Y.; Kishimoto, S.; Nishikawa, K. U.S. Patent 4,355,040 1982.
4. For other angiotensin II receptor antagonists, see (and references within): (a) Carini, D. J.; Duncia, J. V.; Johnson, A. L.; Chiu, A. T.; Price, W. A.; Wong, P. C.; Timmermans, P. B. J. Med. Chem. 1990, 33, 1330. (b) Carini, D. J.; Duncia, J. V.; Aldrich, P. E.; Chiu, A. T.; Johnson, A. L.; Pierce, M. E.; Price, W. A.; Santella, J. B., III; Wells, G. J.; Wexler, R. R.; Wong, P. C.; Yoo, S. E.; Timmermans, P. B. J. Med. Chem. 1991, 34, 2525. (c) Pierce, M. E.; Carini, D. J.; Huhn, G. F.; Wells, G. J.; Arnett, J. F. J. Org. Chem. 1993, 58, 4642. (d) Furukawa, Y.; Kishimoto, S.; Nishikawa, K. U.S. Patent 4,355,040 1982.
5. For other angiotensin II receptor antagonists, see (and references within): (a) Carini, D. J.; Duncia, J. V.; Johnson, A. L.; Chiu, A. T.; Price, W. A.; Wong, P. C.; Timmermans, P. B. J. Med. Chem. 1990, 33, 1330. (b) Carini, D. J.; Duncia, J. V.; Aldrich, P. E.; Chiu, A. T.; Johnson, A. L.; Pierce, M. E.; Price, W. A.; Santella, J. B., III; Wells, G. J.; Wexler, R. R.; Wong, P. C.; Yoo, S. E.; Timmermans, P. B. J. Med. Chem. 1991, 34, 2525. (c) Pierce, M. E.; Carini, D. J.; Huhn, G. F.; Wells, G. J.; Arnett, J. F. J. Org. Chem. 1993, 58, 4642. (d) Furukawa, Y.; Kishimoto, S.; Nishikawa, K. U.S. Patent 4,355,040 1982.
6. Watson, S. P. Synth. Commun. 1992, 22, 2971.
7. Godefroi, E. F.; Loozen, H. J. J.; Luderer-Platje, J. Rec. Trav. Chim. Pays-Bas 1972, 91, 1383.
8. For a general review see: (a) Shriner, R. L.; Neumann, F. W. Chem. Rev. (Washington, D.C.) 1944, 35, 351. (b) Miocque, M.; Fauran, C.; Le Cloarec, A. Y. Ann. Chim. 1972, 7, 89.
9. For a general review see: (a) Shriner, R. L.; Neumann, F. W. Chem. Rev. (Washington, D.C.) 1944, 35, 351. (b) Miocque, M.; Fauran, C.; Le Cloarec, A. Y. Ann. Chim. 1972, 7, 89.
10. (a) Lipinski, C. A.; Blizniak, T. E.; Craig, R. H. J. Org. Chem. 1984, 49, 566.
11. (b) Reiter, L. A. J. Org. Chem. 1984, 49, 3494.
12. (c) Reiter, L. A. J. Org. Chem. 1987, 52, 2714.
13. Marsura, A.; Luu-Duc, C.; Gellon, G. Synthesis 1985, 537.
14. (a) Wells, J. N.; Strahl, M. S. J. Pharm. Sci. 1971, 60, 533.
15. (b) Sletzinger, M.; Reinhold, D.; Grier, J.; Beachem, M.; Tishler, M. J. Am. Chem. Soc. 1955, 77, 6365.
16. Kirby, J. A. U.S. Patent 3,824,292, 1974.
17. For a general review of the preparation and chemistry of halomalonaldehydes, see: Reichardt, C.; Halbritter, K. Angew. Chem., Int. Ed. Engl. 1975, 14, 86.
18. Field, G. F.; Zally, W. J. U.S. Patent 4,194,049, 1980.
19. Reichardt, C.; Halbritter, K. Liebigs Ann. Chem. 1970, 737, 99.
20. Reichardt, C.; Halbritter, K. Liebigs Ann. Chem. 1975, 470.
21. Roblin Jr., R. O.; Winnek, P. S.; English, J. P. J. Am. Chem. Soc. 1942, 64, 570.
22. Silberg, A.; Benko, A.; Csavassy, G. Chem. Ber. 1964, 97, 1684.
23. For a general review of the reactions of amidines with α,β-unsaturated esters, nitriles, and carbonyl derivatives, see Gautier, J.; Miocque, M.; Farnoux, C. C. In The Chemistry of Amidines and Initiates; Patai, S., Ed.; John Wiley & Sons; New York, 1975; Chapter 7, p 324-331.
24. For a general discussion of amidine tautomerism, see: Hafelinger, G.; Fodor, G.; Phillips, B. A. In The Chemistry of Amidines and Imidates; Patai, S., Ed.; John Wiley & Sons; New York, 1975; Chapters 1 and 2.